Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,819 | 4 | 47.7% |
| Food and Beverage | $2,544 | 110 | 43.0% |
| Travel and Lodging | $452.39 | 2 | 7.6% |
| Education | $98.95 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $2,353 | 13 | $0 (2024) |
| LEO Pharma Inc. | $1,191 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $627.34 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $280.24 | 18 | $0 (2024) |
| GENZYME CORPORATION | $245.43 | 9 | $0 (2024) |
| BioCryst US Sales Co., LLC | $172.80 | 6 | $0 (2022) |
| Blueprint Medicines Corporation | $116.37 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $113.85 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $108.70 | 3 | $0 (2024) |
| ALK-Abello, Inc | $83.03 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $676.90 | 28 | AstraZeneca Pharmaceuticals LP ($143.97) |
| 2023 | $3,133 | 48 | CSL Behring ($2,297) |
| 2022 | $503.21 | 27 | AstraZeneca Pharmaceuticals LP ($174.38) |
| 2021 | $1,601 | 16 | LEO Pharma Inc. ($1,170) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Immunology | ||||||
| 12/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $46.98 | General |
| Category: Oncology / Rare Diseases | ||||||
| 07/16/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $30.45 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/03/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Immunology and Neurology | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 03/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 399 | 1,420 | $123,132 | $26,151 |
| 2022 | 10 | 360 | 1,436 | $127,672 | $26,241 |
| 2021 | 12 | 423 | 1,505 | $142,352 | $32,968 |
| 2020 | 14 | 395 | 1,453 | $107,500 | $24,639 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 20 | 217 | $7,220 | $2,149 | 29.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 28 | $8,046 | $1,895 | 23.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 13 | 211 | $6,107 | $1,399 | 22.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 44 | 71 | $6,042 | $1,233 | 20.4% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 15 | 240 | $5,772 | $1,129 | 19.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 21 | 369 | $5,252 | $888.15 | 16.9% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 22 | 29 | $1,466 | $368.20 | 25.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 12 | 12 | $276.00 | $225.83 | 81.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $374.00 | $155.54 | 41.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 143 | $36,276 | $9,013 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 113 | $19,452 | $4,117 | 21.2% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 19 | 217 | $6,970 | $1,718 | 24.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $6,613 | $1,627 | 24.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 39 | 71 | $6,533 | $1,476 | 22.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $6,576 | $1,334 | 20.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 18 | $4,066 | $1,273 | 31.3% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 16 | 235 | $6,662 | $1,210 | 18.2% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 23 | 382 | $6,292 | $975.16 | 15.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 12 | 163 | $5,648 | $871.56 | 15.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 17 | 19 | $465.12 | $293.70 | 63.1% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 18 | 22 | $1,105 | $285.13 | 25.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 15 | $510.00 | $247.80 | 48.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $331.00 | $197.91 | 59.8% |
About Melanie Wayne, FNP
Melanie Wayne, FNP is a Family healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1912353657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melanie Wayne, FNP has received a total of $5,914 in payments from pharmaceutical and medical device companies, with $676.90 received in 2024. These payments were reported across 119 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($2,819).
As a Medicare-enrolled provider, Wayne has provided services to 1,577 Medicare beneficiaries, totaling 5,814 services with total Medicare billing of $110,000. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Allergy & Immunology
- Location Eugene, OR
- Active Since 05/12/2016
- Last Updated 07/03/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1912353657
Products in Payments
- DUPIXENT (Biological) $354.13
- TEZSPIRE (Biological) $336.97
- NUCALA (Biological) $205.04
- FASENRA (Biological) $154.14
- Orladeyo (Drug) $139.80
- AYVAKIT (Drug) $100.78
- Xolair (Biological) $78.08
- FARXIGA (Drug) $70.65
- Hizentra (Biological) $69.16
- Xembify (Biological) $64.52
- PANZYGA (Biological) $54.70
- TAKHZYRO (Biological) $50.81
- BREZTRI (Drug) $47.58
- YUPELRI (Drug) $46.18
- XOLAIR (Drug) $41.35
- TRELEGY ELLIPTA (Drug) $40.82
- GLASSIA (Biological) $38.73
- RINVOQ (Biological) $34.74
- AREXVY (Drug) $34.38
- ORLADEYO (Drug) $33.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Eugene
Rose Boscaino, Arnp, ARNP
Family — Payments: $1,928
Angela Loveless, Arnp, ARNP
Family — Payments: $1,492
Ahnya Booze-Love, Np, NP
Family — Payments: $1,099
Emma Nunez, Np, NP
Family — Payments: $1,066
Virginia Slaughter, Fnp-C, FNP-C
Family — Payments: $1,053
Erika Backstrom, Fnp, FNP
Family — Payments: $885.71